Department of Radiology

Publications

2024

Abdel-Rahman SA, Santini BL, Calvo-Barreiro L, Zacharias M, Gabr M. Design of cyclic peptides as novel inhibitors of ICOS/ICOSL interaction. Bioorg Med Chem Lett. 2024:129599.

Mosconi L, Williams S, Carlton C, Zarate C, Boneu C, Fauci F, et al. Sex-specific associations of serum cortisol with brain biomarkers of Alzheimer's risk. Sci Rep. 2024;14(1):5519.

Ivanidze J, Chang SJ, Haghdel A, Kim JT, RoyChoudhury A, Wu A, et al. [Ga68] DOTATATE PET/MRI-Guided Radiosurgical Treatment Planning and Response Assessment in Meningiomas. Neuro Oncol. 2024.

2023

Abdel-Rahman SA, Rehman AU, Gabr MT. Discovery of First-in-Class Small Molecule Inhibitors of Lymphocyte Activation Gene 3 (LAG-3). ACS Med Chem Lett. 2023;14(5):629-635.

Osborne JR. Predictive Value of Genomic Classifier Scores and Transcriptomic Data for Prostate Cancer Distant Metastasis Risk: A Multicenter Retrospective Study.. 2023.

Rodriguez J, Martinez G, Mahase S, Roytman M, Haghdel A, Kim S, et al. Cost-Effectiveness Analysis of 68Ga-DOTATATE PET/MRI in Radiotherapy Planning in Patients with Intermediate-Risk Meningioma. AJNR Am J Neuroradiol. 2023;44(7):783-791.

Calvo-Barreiro L, Talagayev V, Pach S, Abdel-Rahman SA, Wolber G, Gabr MT. Discovery of ICOS-Targeted Small Molecules Using Pharmacophore-Based Screening. ChemMedChem. 2023;18(23):e202300305.

Stangl-Kremser J, Ricaurte-Fajardo A, Subramanian K, Osborne JR, Sun M, Tagawa ST, et al. Response to RL-225Ac in prostate cancer: Effect of prior treatment with RL-177Lu: A systematic review of the literature. Prostate. 2023;83(10):901-911.

Subramanian K, Osborne JR. PSMA PET/CT cost-effectiveness analysis in the USA: a response to a published commentary. Eur J Nucl Med Mol Imaging. 2023;50(12):3509-3510.

Mauguen A, Grewal RK, Augensen F, Abusamra M, Mahajan S, Jayaprakasam VS, et al. The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool for the management of well-differentiated thyroid cancer patients. Eur J Nucl Med Mol Imaging. 2023;50(10):2971-2983.